Revenue Recognition

9 Months Ended

Sep. 30, 2025

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Note 4. Revenue Recognition

Teknova recognizes revenue from the sale of manufactured products and services when the Company transfers control of promised goods or services to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Control is transferred when the customer has the ability to direct the use of and obtain benefits from the goods or services. The majority of the Company’s sales agreements contain performance obligations satisfied at a point in time when control is transferred to the customer.

Teknova’s revenue, disaggregated by product category, was as follows (in thousands):

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2025		2024		2025		2024
Lab Essentials	$	8,308	$	7,161	$	24,217	$	22,065
Clinical Solutions		1,706		1,964		4,928		5,247
Other		440		451		1,391		1,168
Total revenue	$	10,454	$	9,576	$	30,536	$	28,480

Teknova’s revenue, disaggregated by geographic region, was as follows (in thousands):

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2025		2024		2025		2024
United States	$	9,832	$	9,057	$	28,881	$	27,155
International		622		519		1,655		1,325
Total revenue	$	10,454	$	9,576	$	30,536	$	28,480